ISRG
INTUITIVE SURGICAL INC
NASDAQ · Healthcare · Medical - Instruments & Supplies · US
$448.76
+1.03%Year over year
Reported trailing growth
- Revenue
- +20.5%
- EBITDA
- +14.1%
- EBIT
- +16.6%
- EPS
- +8.8%
- Free cash flow
- +58.4%
- Operating cash flow
- +38.1%
Forward estimates
Based on analyst estimates
- Revenue
- +12.1%
- EBITDA
- +39.0%
- EPS
- +44.3%
Three-year CAGR
- Revenue
- +17.4%
- EBITDA
- +26.5%
- EBIT
- +23.1%
- Net income
- +29.3%
- EPS
- +29.1%
- Free cash flow
- +37.5%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Sep 1, 2026